{"id":811,"date":"2019-05-16T07:09:20","date_gmt":"2019-05-16T05:09:20","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=811"},"modified":"2023-04-25T15:13:23","modified_gmt":"2023-04-25T13:13:23","slug":"business-development-innovation","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/services\/management-support\/business-development-innovation\/","title":{"rendered":"Business development and Innovation"},"content":{"rendered":"\n
The Business development and Innovation Area, has the purpose of connecting academia and industry in order to promote innovative ideas to the market and therefore to society, by supoporting professionals along the process.<\/p>\n
The Area is responsible for evaluating the innovation projects created at IDIBELL in order to encourage the establishment of research-industry translational collaborations. It is composed by two units: Business development and Innovation.<\/p>\n
The Innovation Unit<\/strong>\u00a0 is in charge of evaluating and valuing innovative research projects and supporting the generation of project development strategies and their protection through industrial\/intellectual property, as well as looking for industrial partners for financing and transfering to market.<\/p>\n The Business Development Unit<\/strong> is in charge of seeking alliances, proposing strategies for the profitability of research projects and raising new institutional business opportunities, as well as monitoring all agreements already signed with the industry.<\/p>\n\t\t\t\t\tUnits<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t It was in 2021, when IDIBELL began the process of implementing the management system under the UNE 166002:2014 Standard, being accredited for the first time and successfully passing the annual audits carried out until reaching the current certificate in accordance with the UNE 166002:2021 standard.<\/p>\n\t\t\t\t\tEATRIS accreditation<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t The Business Development and Innovation Area is accredited as an expert center in innovation, business development and regulation by EATRIS. This accreditation opens IDIBELL the possibility of offering services and strategic collaborations to academic and research centers throughout Europe.<\/p>\n EATRIS is the European network of research infrastructures in translational medicine whose objective is to establish a specialized infrastructure in biomedicine to optimize the access of basic research results to clinical applications. Through a network of experts, EATRIS offers decentralized expert services in key areas of medical product development, from the validation process of therapeutic targets to the first phases of clinical trials.<\/p>\n <\/p>\n Business development and Innovation The Business development and Innovation Area, has the purpose of connecting academia and industry in order to promote innovative ideas to the market and therefore to society, by supoporting professionals along the process. The Area is responsible for evaluating the innovation projects created at IDIBELL in order to encourage the establishment […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":771,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-811","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-03-06 01:54:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=811"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/811\/revisions"}],"predecessor-version":[{"id":22542,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/811\/revisions\/22542"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/771"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
The IDIBELL business development and innovation area is accredited with the UNE 166002:2021 certification. This seal certifies that IDIBELL is capable of generating and managing innovation projects, systematizing R+D+I activities and ensuring that they are carried out effectively and efficiently, specifically in the development and innovation of drugs, biomarkers, medical devices and software clinical field within the fields of oncology, neuroscience, translational and regenerative medicine.<\/p>\n
<\/a><\/p>\n\t\t\t\t
\n
\n\t\tMiguel \u00c1ngel Souto Mora\n\t<\/h4>\n
\n\t\tCONTACT\n\t<\/h4>\n
\n\t\t\n\t\tInnovation\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t+34 93 607 38 00 + Ext 3781\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tArea Director\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tHeads of Unit \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tManagers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tAdministrative support\t\t\t\t<\/a>\n\t\t\t\t\t\tArea Director\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n\t\tRelated news\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tKickoff to the XarSMART initiative, which aims to promote the transfer of medical technology in Catalonia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t04\/04\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAtG Therapeutics completes a seed financing round raising more than half a million euros<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/07\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe spin-off from IDIBELL Aptadel Therapeutics receives European support from Eurostars<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t26\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe innovation in science education project STARS GAME implements the first version of its escape room game in four high schools in L’Hospitalet<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t05\/01\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAn IDIBELL project on rehabilitation of people with facial paralysis is promoted by Sinergia Innova<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/01\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tFrom lab to market: the fourth edition of the Accelerator Meeting Point promotes Bellvitge’s biomedical innovation<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t16\/12\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe spin-off Aptadel selected to be part of BCN Health Booster<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t26\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL is committed to innovation on its 2nd Career Day<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t22\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tThe Innovation and Business Development Unit of IDIBELL participates in the largest congress of biotechnology industries in Europe<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL’s Innovation Unit receives the UNE 166002:2014 certification<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/08\/2021\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"